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Abstract
Vitamins are an essential part to wellbeing. This was not something always known however, as the Germ theory
was the accepted thesis of the 18th century. It was found that certain accessory factors helped mitigate and even cure
these diseases such as beriberi, scurvy, and rickets. Accessory factors, later coined vitamins by Casimir Funk, are an
essential constituent of the human diet. Vitamin D is technically not a vitamin but functions as a steroid hormone
whose most well-known purpose is calcification of the human skeleton. This helps prevent osteomalacia in adults
and rickets, a serious problem in children due to their developmental stages. But besides its well-known role, vitamin
D also has other important non-calcification purposes, including being a possible anticancer agent. Calcitriol (1,25
dihydroxycholecalciferol, vitamin D3) has found to treat certain cancers in various ways: from the VDR-RXR complex
to analogs being able to decrease tumor growth, lowering expression of stem cell marker genes, and inhibition of the
Wnt pathway. Although there is promise in its effectiveness based on studies of squamous cell carcinoma, prostate,
breast, colon, and ovarian cancer; hypercalcemia, lack of consistent data, and insufficient clinical trials are serious
issues that constantly get in the way of progression of vitamin D’s legitimacy as a solution.

Keywords: Vitamin D, Calcitriol, Disease, Cancer, Nutrient, Human health
Abbreviations: CSC: Cancer Stem Cell; CYP: Cytochrome P; PTH: Parathyroid Hormone; SCC: Squamous Cell
Carcinoma; UV: Ultraviolet; VDR: Vitamin D Receptor

Introduction
At the beginning of the 18th century, scientists
believed that a human was perfectly capable of being
healthy based on only 4 necessary nutritional factors:
proteins, carbohydrates, fats, and minerals. However,
some diseases would severely affect human population
at the time. Diseases such as beriberi, scurvy, pellagra,
and rickets would baffle researchers as there weren’t
any abnormal microorganisms found in the body at the
time. The reason why these diseases were so difficult
to understand was due to the accepted hypothesis of
diseases at the time known as Germ theory. It states
that any disease is due to some action or presence of a
J Nutri Bio, 4(2): 236-243 (2018)

microorganism within the body [1]. Scientists later found
out that these diseases were due to a lack of a specific
component in the body [1]. According to Frederick
Gowland Hopkins, states “no animal can live upon a
mixture of pure protein, fat, and carbohydrate, even if
necessary inorganic materials are supplied, an animal
still can’t flourish” [2].

Historical background
During the Franco-Prussian war, the Siege of Paris
occurred between 1870 and 1871 where several supplies
for the French were cut off. Infant mortality rate was
absurdly high during this period of time as there was a
lack of milk. Experiments with rats conducted by Wilhelm
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Stepp found that milk gave them normal growth; however,
a milk substitute synthesized by opportunists (people
who wanted to take advantage of the situation) failed to
provide sustenance to the infants [3][4]. This lead to the
conclusion that a lipid substance was found in milk which
is essential to mice growth [5]. These accessory factors
were found in very small amounts. These accessory
factors, coined by Hopkins, were later termed vitamins by
Casimir Funk in 1912, and were linked to solving vitamin
deficient diseases [6][7]. Beriberi due to a lack of Vitamin
B-1 (thiamin), Pellagra insufficient B-3 (niacin), scurvy
insufficient Vitamin C, and rickets insufficient Vitamin
D. Sir Edward Mellanby (1884-1955) was a researcher
at King’s College for Women in London [8]. It was at this
place in 1918-1919 that he discovered an accessory factor
that played an essential part in preventing rickets. He fed
puppies a diet that was found to produce rickets by giving
them two different diets (Table 1). Milk was limited to less
than 200 mL, if not, a rachitic diet would not be produced
[9].
Table 1: Rachitic diets for the puppies.

rickets are a deficiency of a certain accessory factor. Later
research my Mellanby and McCollum found out that the
factor that prevents rickets and even cures them was a
new vitamin termed Vitamin D [10].

Discussion
Vitamin D

Meat

Protein of meat

Vitamin D (taken together) is technically not a vitamin.
This is due to the fact that vitamins are substances that
can’t be synthesized by our body and must be obtained by
the foods we eat. Vitamin D, although it must be obtained
from the environment, is mostly gathered from how long
we are exposed to the sun as a typical diet won’t give
sufficient amounts because of how little sources come
from animals (the most common source being fatty fish
such as tuna, salmon, or cod liver oil). Our geographic
location and atmospheric pressure also explains why
some regions of the world have people more susceptible
to vitamin D deficiency diseases [11]. It’s important to
note one can be Vitamin D deficient, but not be able
to over consume Vitamin D from being exposed to UV
radiation [12]. The only way an overdose could happen is
due to excessive amounts of Vitamin D supplementation,
which could be just as fatal as under consumption
[12]. Vitamin D, however, is actually considered to be a
steroid hormone. The active form of Vitamin D, known as
Calcitriol (Figure 1), is a steroid hormone because it can
regulate levels of calcium and phosphorus in our body.
Calcitriol is capable of being synthesized within our body;
this is done within our kidney and liver. Cholecalciferol,
the inactive form of Vitamin D (Figure 1), is generated in
our skin when UV radiation is absorbed by the precursor
molecule, 7-dehydrocholesterol. Cholecalciferol is
the supplement that can be found in stores where
overconsumption can be toxic. This makes Vitamin D
technically not a vitamin because they are unable to be
synthesized in our body [12].

Watery extract of meat

Casein

HO

Malt extract

Linseed oil

Commercial yeast extract

10g of yeast a day

Rachitic Diets
Diet 1

Diet 2

Milk

Milk

Rice

Bread

Oatmeal
NaCl
Other puppies were given this nutrition with added
foods into the diet, this was done to observe if some
factor found in said foods could inhibit rickets (Table 2).

Table 2: Diets for two different groups.
Group I
(Prevented)

Group II
(Did not prevent)

500 c.c of milk everyday

HO
H

HO

H

Butter
Margarine
Cod liver oil
It was concluded as there were some sort of accessory
factors that prevents rickets and is fat-soluble as these
were found in the extract of protein and fat [10]. This
also showed that fats, proteins, and carbohydrates had
no influence on the production of rickets, merely that
J Nutri Bio, 4(2): 236-243 (2018)

H H
H

Calcitriol

OH

H
Cholecalciferol

Figure 1: Structures of Calcitriol and Cholecalciferol.
Pharmacokinetics
Human skin contains a sterol derivative known as
7-dehydrocholesterol. Once this compound is exposed
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to UV radiation it converts to the inactive form known as
cholecalciferol (typically known as Pre-Vitamin D3) [12].
This cis-cis conformer is thermodynamically unfavorable
and is energetic but is the only form that isomerizes
to Vitamin D3. Vitamin D3 (or D2 if obtained from plants
known as ergo sterol) is not biologically active however
they still need to be converted to its physiologically active
form, calcitriol [12]. First, cholecalciferol is hydroxylated
(introduced a hydroxyl group) inside the liver where it
becomes 25-hydroxy derivative of Vitamin D. This is done
under the influence of the enzyme 25-hydroxylase. Next,
it must be transported to the kidney where it again is
hydroxylated, acting as a substrate for 1-alpha hydroxylase,
where it is converted to 1,25-dihydroxycholecalciferol,
the active form (Figure 2). It travels throughout the body
via blood with its carrier protein, DBP (vitamin D-binding
protein) [12]. Also, it’s worthy to mention that since it is
difficult to lead a vitamin D fortified diet, it is possible
for food companies to irradiate Vitamin D into our food,
fortifying it [13].

UV Radiation

In kidney

In liver

HO
7-Dehydrocholesterol
HO

HO
Cholecalciferol
(Inactive Vitamin D)

25-Hydroxycholecalciferol

HO

OH
Calcitriol

could occur, obviously from lacking Vitamin D; this could
be due to not going out to get direct UV radiation or
lacking from the diet. Although it was quite difficult to get
Vitamin D from our diet, it is possible to irradiate many
of our foods with Vitamin D and commonplace groceries,
such as milk, have become Vitamin D fortified. There is
debate however, about the effectiveness from fortified
Vitamin D2 found in most foods as compared to D3
obtained from the sun. Another reason for osteomalacia
occurring could be due to kidney or liver problems, this
can halt the mechanistic formation of Vitamin D in our
body, and even if we do have a Vitamin D rich diet and are
exposed daily to the sun, we will not be getting anything
out of it since our body isn’t able to synthesize the active
form. Osteomalacia in children is known as rickets and
is considerably more severe as children’s bones are still
forming. An example of the severity of rickets is bowed
legs that are curved outward as well as other skeletal
deformities [16]. Osteoporosis can also occur as a
consequence of years of insufficient vitamin D thinning
the bones and making them brittle. An insufficient
calcium intake can prove dangerous for the elderly as a
fall could prove a trip to the hospital over a broken hip
[17]. Despite Vitamin D being most-well known for its role
in bone formation, recent studies have shown that it also
displays excellent noncalcemic functions. The reason is
due to its Vitamin D receptor and analogs.

Vitamin D receptor (VDR)
Figure 2: Formation of Calcitriol from
7-Dehydrocholesterol.

Calcification
Activated Vitamin D cannot play any ‘active’ role in
human body without the Vitamin D receptor, a member
of the nuclear receptor family whose purpose is allowing
Calcitriol’s gene expression [14]. The most well-known
function of Vitamin D is regulation of calcium in human
body. This is monitored by the serum calcium levels in
our blood, kidneys, and parathyroid hormone. If human
serum calcium levels are found in low amounts, the
parathyroid gland secretes a hormone, which responds
to these levels (as well as phosphate) and secretes PTH
(parathyroid hormone). This hormone then signals
the kidney to begin producing activated Vitamin D and
pulling calcium from our bones and into our circulatory
system. This is done until the calcium levels have become
balanced. This is all an example of our bodies’ excellent
practice of homeostasis [15]. By this relatively simple
function, it prevents disastrous effect that might occur
in the body, including osteomalacia: a softening of the
bones. There are a number of reasons why osteomalacia
J Nutri Bio, 4(2): 236-243 (2018)

The Vitamin D receptor regulates many roles of
vitamin D in human body due to its versatility. Calcitriol
executes its functions only through this receptor. VDR
has several binding domains for several occupants. The
C-domain for binding to the DNA, E-domain for ligandbinding, and an activating F-domain [18]. This means that
VDR standardizes all the functions Vitamin D performs.
This is excellent, however may create complications in
preparation of its analogs and their functions. Regardless,
this 427 amino acids’ constituted receptor works with
Vitamin D-responsive elements (VDREs) found at the
starting site of the specified gene. These VDREs’ 5’ arm
attaches to the RXR, and its 3’ arm to the VDR [18]. This
in turn heterodimerizes as well as acquiring an activator
[18].
VDR possesses remarkable versatility. Interestingly, it’s
found in many places including enterocytes, osteoblasts,
and more recently discovered in parathyroid gland cells,
keratinocytes, colon cells, and more [19]. Because VDR is
present in these locations strongly suggests its functions
are far beyond the scope of just bone formation. For
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example, pioneering research by Suda et al. (2015)
found that calcitriol can help terminally differentiate
between promyelocytes and monocytes, precursors
of the bone dissolving and absorption cell: osteoclasts.
This demonstrates the importance in production of
osteoclasts by use of Vitamin D [20]. As mentioned
before, VDR is found in parathyroid gland cells, this has
been found to be therapeutically useful in the treatment
of renal osteodystrophy: a disease of the bones occurring
due to kidneys being unable to regulate calcium and
phosphorus levels in the blood. Treatments so far were
mainly through the use of phosphorus retention, which
in turn inhibited hyperphosphatemia [21]. This allowed
serum calcium concentrations to return to regular levels
[21]. Studies have also found that calcitriol (and analogs)
also function to prevent parathyroid gland cells from
rapidly multiplying. When the kidneys aren’t working
as intended (renal failure), can affect circulation of
calcium in the body, causing hyperproliferation of the
parathyroid gland, secreting large amounts of parathyroid
hormone, resulting in secondary hyperparathyroidism
[22]. Regulation through calcitriol maintains healthy
parathyroid glands in patients undergoing dialysis [22].
Vitamin D also has shown to have some therapeutic
effect in treatment of certain autoimmune diseases such
as multiple sclerosis and regulation of type 1 diabetes
mellitus by increasing lag time, resulting in more time
before diabetes actually occur [23][24]. Further studies
are required to make firm conclusion.

form easily being converted to calcitriol inside cancer
cells [29][30]. This also means that since it is not under
the influence of the 3 hormones, it can exert high levels
of calcitriol concentration [31], but there is no question
of hypercalcemia being a danger as of right now [27][28]
[32]. CYP24A1 is also found within cancer cells, yet serves
no anticancer therapeutic effects, actually it suppresses
calcitriol’s influence on them [33][34][35] classifying it
as an oncogene (gene that may cause growth of cancer
cells) [36]. Luckily, there are ways around this gene by
use of cytochrome P450 inhibitors such as genistein
[37], ketoconazole [38], and liarozole [39]. This in turn
allows calcitriol’s influence to be prevalent once again.
Unfortunately the use of these inhibitors enhances the
calcemic effects of calcitriol, introducing hypercalcemia
as a risk once more [40]. Caution must be taken when
using these compounds in tandem. Furthermore,
expression of CYP27B1 depends on the tumor, its
progression, and targeted organ [29][30][41][42][43].
Regardless, this cytochrome metabolizing enzyme
shows potential in being able to influence cancer-related
pathways for treatment of it (information was obtained
by performing studies on patients with breast, prostate,
and other cancers) [44]. In a nutshell, calcitriol influences
the activity of certain cytochrome metabolizing enzymes
and subsequent interactions with various cancer cells.
An outlined discussion is presented below considering
the types of cancer based on organs and its promise as a
future therapeutic agent.

Cancer and Vitamin D

Leukemia

It is well-known that calcitriol and VDR have increased
utility and influence on the human body. It’s also worthy
to restate that it can regulate gene expression, allowing
influence to several signaling pathways involved in
such processes like apoptosis and proliferation. This is
especially seen when discussing Vitamin D’s impact on
the following cytochrome P450 enzymes.

CYP27B1 and CYP24A1
These renal enzymes are regulated by three hormones:
calcitriol, fibroblast growth factor 23, and parathyroid
hormone [25][26]. CYP27B1 is found in several extrarenal
areas of interest. It’s also found in cancer cells, allowing
it to impose anticancer influence [27]. Although CYP27B1
is regulated by the hormones mentioned above, it’s only
regulated as renal CYP27B1, their influence on extra renal
CYP27B1 is nonexistent and cannot regulate its effects
[27][28]. Synthesis of this enzyme depends on calcidiol
substrate concentration. This indicates that Vitamin D
could be a possible anticancer agent due to the inactive
J Nutri Bio, 4(2): 236-243 (2018)

An abnormality of the body’s bone marrow forming
cancerous white blood cells, Leukemia is a cancer that
affects less than 200,000 people in the United States per
year [45]. Depending on its aggression, treatment may
vary [46]. Calcitriol can regulate mineral metabolism in
the body and can impose a differentiation inducing factor
on this leukemic cell line (HL60), converting them into end
cells (this means that it can transform a cancerous cell into
a completely different cell) [47]. In vitro and in vivo tests
were performed on patients who had preleukemia. In
vitro study, calcitriol had a differentiating factor induced
on the leukemic cells, but in vivo the results were not
as well. Therapeutically speaking, it was virtually absent
as it didn’t prevent 7 of the 18 patients from developing
leukemia and 9 others developed hypercalcemia [47]. An
analog that does not impose calcemic effects would be
needed in order to make this therapy effective in patients
suffering leukemia [47].
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Squamous cell carcinoma (SCC)
Often regarded as one of the most common skin
cancers, squamous cell carcinoma usually affects the
epidermal layers of the body. The reason as to why it’s
much more common than leukemia (1 million diagnosed
annually) could be due to too much exposure to UV
radiation. Being exposed to the sun year-round and
being a participant in tanning beds could proliferate
abnormal cell growth to the exposed areas [48]. Calcitriol
has the ability to change the expression of proteins that
regulate the cell cycle in cancer cells resulting in the
dephosphorylation of a retinoblastoma protein (function
to suppress tumors and regulate cell cycle, doesn’t
function in different cancers). Calcitriol also is known
to down modulate a possible oncogene known as p21
(WAF1/CIP1), an inhibitor thought to suppress tumors
[49], but studies have shown that it prevents apoptosis
and encourages rapid cancer cell growth. Finally, calcitriol
also increases expression of p27Kip1, another cyclindependent kinase inhibitor whose function is to slow down
or even stop the cell cycle from proceeding. Calcitriol,
along with help from dexamethasone, have shown to
prevent SCC proliferation, and this is done by preventing
cell cycle progression rather than programmed cell death
[50] through apoptosis. This is therapeutically useful as
studies were shown to be effective both in vitro and in
vivo.

4 experimental groups. The rats treated with calcitriol
had tumor progression slowed, and with a higher dosage
it also lowered the progression further, but with marked
weight loss and development of hypercalcemia. On the
other hand, rats with EB1089 showed tumor progression
similar to that of calcitriol, without marked weight loss
or hypercalcemia on either of the two groups [52]. There
is much promise to be shown here and if possible how
EB1089 could be incorporated to other cancers. This is
truly the first successful synthetic analog that can be
used for anticancer therapy. It is also worthy to note that
EB1089 was able to successfully and effectively induce
apoptosis of two carcinoma cell lines: SW620 and PC/JW
[53]. This indicates that EB1089, along with possibly other
synthetic analogues produced, could offer an alternative
solution to colorectal cancer.

HO

HO
H

H
H

H

H
OH

Figure 3: Structure of EB 1089.

Prostate and Colon cancers

Breast cancer

Prostate cancer is a very frequent cancer (males)
worldwide. As many as 3 million men a year are diagnosed
with prostate cancer although in most of the cases
the rate of proliferation in prostate cancer is relatively
slower than many other types of cancer. Treatment is
simple if detected early and sometimes not necessary,
however when it becomes metastatic, its aggression and
advancement can be deadly [51]. Calcitriol demonstrated
huge potential to fight against prostate cancer as found
in vitro, however, with frequent uptake, the chance of
hypercalcemia raises. EB1089, a synthetic analogue of
Vitamin D (Figure 3), however might resolve this issue. It
has the same anticancer effects that calcitriol would have
on prostate cancer cells but does not induce a calcemic
effect of any kind [52]. EB1089 and calcitriol were injected
in various doses to 4 groups of male rats. Each group
had 10 rats treated with MAT-Lylu cells (a cell line that
induced proliferation of prostate tumor cells in male
rats). There was also an extra group that served as the
control, totaling 50 rats in 5 groups overall. The results
were as expected: the control group had increased
amount of tumor progression as compared to any of the

Breast cancer is known as the most commonly
diagnosed cancer, being the 2nd most lethal type of
cancer found in women. It initiates by the use of tumorinitiating cells (also known as cancer stem cells) that
creates cancer cells and continues to do so repeatedly
at the site of the original tumor mass. The significance of
this study was not necessarily if calcitriol or vitamin D as
a dietary supplement could treat breast cancer, but how
it does so. A mouse mammary tumor virus was induced
in rats and later treated with calcitriol injections or a diet
focused on vitamin D supplementation [54]. The results
were not very exciting, but progressive toward support its
push to therapeutic legitimacy. What was surprising was
how effective calcitriol was when combined with ionizing
radiation therapy, results far better than what either one
could’ve done alone, creating a synergistic effect. The way
it halted tumor progression was hypothesized to have
been located at the Wnt/β-Catenin pathway [55]. This
pathway is very important as it regulates stem cells that
are considered pluripotent, meaning that it can create
any kind of cell needed in the human body.

J Nutri Bio, 4(2): 236-243 (2018)
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Ovarian cancer
Ovarian Cancer is a perplexing cancer for females. It’s
undetectable in early stages, and symptoms usually don’t
show up until it’s become advanced. There has been no
real information on how to prevent ovarian cancer [56]
although there are many instances that ovarian cancer
functions the same way that breast cancer does via
cancer stem cells. Interestingly, xenograft models of mice
produced with ovarian cells from human, was shown that
calcitriol therapy greatly slowed down tumor growth [57].
This was done by disrupting its cancer stem cells through
the Wnt signaling pathway. The capacity to create its
form under cultured conditions, the frequency of CSCs,
was done in vivo by limited dilution analysis [57]. Much
promise by seeing repeated paths or similar means of
action by calcitriol indicates some form of consistency in
its method of approach.

Conclusion
In conclusion, vitamin D and its analogs demonstrated
key role in regulating various diseases in human including
cancer. The mechanism of action is not completely
understood yet. Accordingly, further research is required
to explore its therapeutic potential more appropriately
for human wellbeing.

Conflicting interests
The authors have declared that no conflicts of interests
exist.

Acknowledgements
Thanks are accorded to the Department of Chemistry
(College of Sciences), The University of Texas Rio Grande
Valley.

References
1. Semba RD. The discovery of the vitamins. Int J Vitam
Nutr Res. 2012;82(5):310-315. doi: http://dx.doi.
org/10.1024/0300-9831/a000124
2. Hopkins FG. The analyst and the medical man. Analyst.
1906;31.
3. Dumas [J. B. A.]. Note Sur La Constitution Du Lait et
Du Sang. Le Monit 1871 Sci. 3 Ser. 1, 778.
4. Stepp W. Versuche über Fütterung mit lipoidfreier
Nahrung. Biochem Z. 1909;22:452.
5. Stepp W. Experimentelle Untersuchungen über die
Bedeutung der Lipoide für die Ernährung. Z Biol.
1911;57:135.
J Nutri Bio, 4(2): 236-243 (2018)

6. Hopkins FG. Feeding experiments illustrating the
importance of accessory factors in normal dietaries.
J Physiol. 1912;44(5-6):425-460. https://www.ncbi.nlm.
nih.gov/pmc/articles/PMC1512834/
7. Funk C. The etiology of the deficiency diseases. Beriberi, polyneuritis in birds, epidemic dropsy, scurvy,
experimental scurvy in animals, infantile scurvy,
ship beri-beri, pellagra. Journal of State Medicine.
1912;20(6):341.
8. Hawgood BJ. Sir Edward Mellanby (1884-1955)
GBE KCB FRCP FRS: nutrition scientist and medical
research mandarin. J Med Biogr. 2010;18(3):150-157.
doi: http://dx.doi.org/10.1258/jmb.2010.010020
9. Mellanby E. The part played by an “accessory factor”
in the production of experimental rickets. Proceedings
of the Physiological Society. 1918;52:xi-xii.
10. Mellanby E. A further demonstration of the part
played by accessory food factors in the aetiology
of rickets. Proceedings of the Physiological Society.
1918;52:liii-liv.
11. Anderson JJB, Toverud SU. Diet and vitamin D: A
review with an emphasis on human function. The
Journal of Nutritional Biochemistry. 1994;5(2):58-65.
doi: http://dx.doi.org/10.1016/0955-2863(94)90018-3
12. VIVO Pathophysiology. http://www.vivo.colostate.
edu/hbooks/pathphys/endocrine/otherendo/
vitamind.html
13. Steenbock H, Black A. Fat-Soluble Vitamins Xvii.
the Induction of Growth-Promoting and Calcifying
Properties in a Ration by Exposure to Ultra-Violet
Light. J Biol Chem. 1924;61(2):405-422. http://www.
jbc.org/content/61/2/405
14. Vitamin D Council. https://www.vitamindcouncil.org/
the-physiology-of-vitamin-d/
15. Vitamin D Council. https://www.vitamindcouncil.org/
parathyroid-glands-and-vitamin-d/
16. Mayo Clinic. https://www.mayoclinic.org/diseasesconditions/osteomalacia/symptoms-causes/syc20355514
17. Mayo Clinic. https://www.mayoclinic.org/diseasesconditions/osteoporosis/symptoms-causes/syc20351968
18. DeLuca HF. Overview of general physiologic features
and functions of vitamin D. Am J Clin Nutr. 2004;80(6
Suppl):1689S-96S. doi: http://dx.doi.org/10.1093/
ajcn/80.6.1689S
19. Jones G, Strugnell SA, DeLuca HF. Current
understanding of the molecular actions of vitamin D.

241

Physiol Rev. 1998;78(4):1193-1231. doi: http://dx.doi.
org/10.1152/physrev.1998.78.4.1193
20. Suda T, Ueno Y, Fujii K, Shinki T. Vitamin D and bone.
J Cell Biochem. 2003;88(2):259-266. doi: http://dx.doi.
org/10.1002/jcb.10331
21. El-Kishawi AMW, El-Nahas AM. Renal osteodystrophy:
review of the disease and its treatment. Saudi J Kidney
Dis Transpl. 2006;17(3):373-382. https://www.ncbi.
nlm.nih.gov/pubmed/16970258
22. Slatopolsky E, Gonzalez E, Martin K. Pathogenesis
and treatment of renal osteodystrophy. Blood
Purif. 2003;21(4-5):318-326. doi: http://dx.doi.
org/10.1159/000072552
23. Cantorna
MT,
Hayes
CE,
DeLuca
HF.
1,25-Dihydroxyvitamin D3 reversibly blocks the
progression of relapsing encephalomyelitis, a
model of multiple sclerosis. Proc Natl Acad Sci U S A.
1996;93(15):7861-7864.
https://www.ncbi.nlm.nih.
gov/pmc/articles/PMC38839/
24. Zella JB, DeLuca HF. Vitamin D and autoimmune
diabetes. J Cell Biochem. 2003;88(2):216-222. doi:
http://dx.doi.org/10.1002/jcb.10347
25. Dusso A, González EA, Martin KJ. Vitamin D in chronic
kidney disease. Best Pract Res Clin Endocrinol Metab.
2011;25(4):647-655. doi: http://dx.doi.org/10.1016/j.
beem.2011.05.005
26. Martin A, David V, Quarles LD. Regulation and function
of the FGF23/klotho endocrine pathways. Physiol Rev.
2012;92(1):131-155. doi: http://dx.doi.org/10.1152/
physrev.00002.2011
27. Höbaus J, Thiem U, Hummel DM, Kallay E. Role of
calcium, vitamin D, and the extrarenal vitamin D
hydroxylases in carcinogenesis. Anticancer Agents
Med Chem. 2013;13(1):20-35. doi: http://dx.doi.
org/10.2174/187152013804487434
28. Adams JS, Hewison M. Extrarenal expression of the
25-hydroxyvitamin D-1-hydroxylase. Arch Biochem
Biophys. 2012;523(1):95-102. doi: http://dx.doi.
org/10.1016/j.abb.2012.02.016
29. Hsu JY, Feldman D, McNeal JE, Peehl DM. Reduced
1alpha-hydroxylase activity in human prostate
cancer cells correlates with decreased susceptibility
to 25-hydroxyvitamin D3-induced growth inhibition.
Cancer Res. 2001;61(7):2852-2856. https://www.ncbi.
nlm.nih.gov/pubmed/11306457
30. Whitlatch LW, Young MV, Schwartz GG, et al.
25-Hydroxyvitamin D-1α-hydroxylase activity is
diminished in human prostate cancer cells and is
J Nutri Bio, 4(2): 236-243 (2018)

enhanced by gene transfer. J Steroid Biochem Mol Biol.
2002;81(2):135-140. doi: http://dx.doi.org/10.1016/
S0960-0760(02)00053-5
31. Wagner D, Trudel D, Van der Kwast T, et al. Randomized
clinical trial of vitamin D3 doses on prostatic vitamin D
metabolite levels and ki67 labeling in prostate cancer
patients. J Clin Endocrinol Metab. 2013;98(4):14981507. doi: http://dx.doi.org/10.1210/jc.2012-4019
32. Swami S, Krishnan AV, Wang JY, et al. Dietary
vitamin D and 1,25-dihydroxyvitamin D (calcitriol)
exhibit equivalent anticancer activity in mouse
xenograft models of breast and prostate cancer.
Endocrinology. 2012;153(6):2576-2587. doi: http://
dx.doi.org/10.1210/en.2011-1600
33. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W,
Reichrath J. Analysis of the vitamin D system in cervical
carcinomas, breast cancer and ovarian cancer. Recent
Results Cancer Res. 2003;164:239-246. https://www.
ncbi.nlm.nih.gov/pubmed/12899526
34. Miller GJ, Stapleton GE, Hedlund TE, Moffat KA. Vitamin
D receptor expression, 24-hydroxylase activity, and
inhibition of growth by 1alpha,25-dihydroxyvitamin
D3 in seven human prostatic carcinoma cell lines. Clin
Cancer Res. 1995;1(9):997-1003. https://www.ncbi.
nlm.nih.gov/pubmed/9816072
35. Skowronski RJ, Peehl DM, Feldman D. Vitamin D and
prostate cancer: 1,25 dihydroxyvitamin D3 receptors
and actions in human prostate cancer cell lines.
Endocrinology. 1993;132(5):1952-1960. doi: http://
dx.doi.org/10.1210/endo.132.5.7682937
36. Albertson DG, Ylstra B, Segraves R, et al. Quantitative
mapping of amplicon structure by array CGH
identifies CYP24 as a candidate oncogene. Nat
Genet.
2000;25(2):144-146.
doi:
http://dx.doi.
org/10.1038/75985
37. Peehl DM, Seto E, Feldman D. Rationale for
combination ketoconazole/ vitamin D treatment of
prostate cancer. Urology. 2001;58(2 Suppl 1):123-126.
https://www.ncbi.nlm.nih.gov/pubmed/11502466
38. Ly LH, Zhao XY, Holloway L, Feldman D. Liarozole
acts synergistically with 1alpha,25-dihydroxyvitamin
D3 to inhibit growth of DU 145 human prostate
cancer cells by blocking 24-hydroxylase activity.
Endocrinology. 1999;140(5):2071-2076. doi: http://
dx.doi.org/10.1210/endo.140.5.6698
39. Swami S, Krishnan AV, Peehl DM, Feldman D.
Genistein potentiates the growth inhibitory effects of
1,25-dihydroxyvitamin D3 in DU145 human prostate
cancer cells: role of the direct inhibition of CYP24

242

enzyme activity. Mol Cell Endocrinol. 2005;241(1-2):4961. doi: http://dx.doi.org/10.1016/j.mce.2005.05.001
40. Wang JY, Swami S, Krishnan AV, Feldman D.
Combination of Calcitriol and Dietary Soy Exhibits
Enhanced Anticancer Activity and Increased
Hypercalcemic Toxicity in a Mouse Xenograft Model
of Prostate Cancer. Prostate. 2012;72(15):1628-1637.
doi: http://dx.doi.org/10.1002/pros.22516
41. Cross HS, Bareis P, Hofer H, et al. 25-Hydroxyvitamin
D(3)-1alpha-hydroxylase and vitamin D receptor
gene expression in human colonic mucosa is
elevated during early cancerogenesis. Steroids.
2001;66(3-5):287-292. https://www.ncbi.nlm.nih.gov/
pubmed/11179736
42. Lopes N, Sousa B, Martins D, et al. Alterations in
Vitamin D signalling and metabolic pathways in
breast cancer progression: a study of VDR, CYP27B1
and CYP24A1 expression in benign and malignant
breast lesions Vitamin D pathways unbalanced in
breast lesions. BMC Cancer. 2010;10:483. doi: http://
dx.doi.org/10.1186/1471-2407-10-483
43. Townsend K. Autocrine Metabolism of Vitamin D in
Normal and Malignant Breast Tissue. Clinical Cancer
Research. 2005;11(9):3579-3586. doi: http://dx.doi.
org/10.1158/1078-0432.CCR-04-2359
44. Feldman D, Krishnan AV, Swami S, Giovannucci E,
Feldman BJ. The role of vitamin D in reducing cancer
risk and progression. Nat Rev Cancer. 2014;14(5):342357. doi: http://dx.doi.org/10.1038/nrc3691
45. Mayo Clinic. https://www.mayoclinic.org/diseasesconditions/leukemia/symptoms-causes/syc20374373

Trump DL, Johnson CS. 1,25-Dihydroxycholecalciferol
(1,25-D3) inhibits the growth of squamous cell
carcinoma and down-modulates p21(Waf1/Cip1) in
vitro and in vivo. Cancer Res. 1999;59(11):2644-2649.
https://www.ncbi.nlm.nih.gov/pubmed/10363987
51. Mayo Clinic. https://www.mayoclinic.org/diseasesconditions/prostate-cancer/symptoms-causes/syc20353087
52. Lokeshwar BL, Schwartz GG, Selzer MG, et al. Inhibition
of prostate cancer metastasis in vivo: a comparison
of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Cancer Epidemiol Biomarkers Prev. 1999;8(3):241-248.
https://www.ncbi.nlm.nih.gov/pubmed/10090302
53. Díaz GD, Paraskeva C, Thomas MG, Binderup
L, Hague A. Apoptosis is induced by the active
metabolite of vitamin D3 and its analogue EB1089
in colorectal adenoma and carcinoma cells: possible
implications for prevention and therapy. Cancer Res.
2000;60(8):2304-2312. https://www.ncbi.nlm.nih.gov/
pubmed/10786699
54. Jeong Y, Swami S, Krishnan AV, et al. Inhibition of
Mouse Breast Tumor-Initiating Cells by Calcitriol and
Dietary Vitamin D. Mol Cancer Ther. 2015;14(8):19511961. doi: http://dx.doi.org/10.1158/1535-7163.MCT15-0066
55. Angeloni V, Tiberio P, Appierto V, Daidone MG.
Implications of stemness-related signaling pathways
in breast cancer response to therapy. Semin Cancer
Biol. 2015;31:43-51. doi: http://dx.doi.org/10.1016/j.
semcancer.2014.08.004

46. Medline Plus. https://medlineplus.gov/leukemia.html

56. Mayo Clinic. https://www.mayoclinic.org/diseasesconditions/ovarian-cancer/symptoms-causes/syc20375941

47. Koeffler HP, Hirji K, Itri L. 1,25-Dihydroxyvitamin D3:
in vivo and in vitro effects on human preleukemic and
leukemic cells. Cancer Treat Rep. 1985;69(12):13991407.

57. Srivastava AK, Rizvi A, Cui T, et al. Depleting ovarian
cancer stem cells with calcitriol. Oncotarget.
2018;9(18):14481-14491.
doi:
http://dx.doi.
org/10.18632/oncotarget.24520

48. Skin Cancer Foundation. https://www.skincancer.org/
skin-cancer-information/squamous-cell-carcinoma
49. Gartel AL. p21(WAF1/CIP1) and cancer: a shifting
paradigm? Biofactors. 2009;35(2):161-164. doi: http://
dx.doi.org/10.1002/biof.26
50. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM,

Copyright: © Hassan et al. This is an Open Access article distributed under the terms of
the Creative Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
J Nutri Bio, 4(2): 236-243 (2018)

243

